Jianghong Deng

2.6k total citations · 1 hit paper
54 papers, 1.9k citations indexed

About

Jianghong Deng is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jianghong Deng has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jianghong Deng's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Advanced Proteomics Techniques and Applications (9 papers) and Advanced Biosensing Techniques and Applications (9 papers). Jianghong Deng is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Advanced Proteomics Techniques and Applications (9 papers) and Advanced Biosensing Techniques and Applications (9 papers). Jianghong Deng collaborates with scholars based in China, United States and Italy. Jianghong Deng's co-authors include Lance A. Liotta, Julia Wulfkuhle, Emanuel F. Petricoin, Hao Zhang, Emanuel Petricoin, Yanqin Yang, Joseph B. Margolick, Peihua Gu, Jiangbing Zhou and Ying Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jianghong Deng

49 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

2007 539 citations Jiangbing Zhou, Julia Wulfkuhle et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jianghong Deng China	21	1.2k	596	337	235	225	54	1.9k
Andrei Turtoï France	27	1.1k 0.9×	580 1.0×	483 1.4×	149 0.6×	122 0.5×	64	1.9k
José M.A. Moreira Denmark	31	1.8k 1.5×	656 1.1×	670 2.0×	118 0.5×	502 2.2×	79	2.8k
Adele Marrangoni United States	22	855 0.7×	861 1.4×	354 1.1×	103 0.4×	84 0.4×	28	2.0k
Ayodele Alaiya Saudi Arabia	32	1.6k 1.3×	735 1.2×	345 1.0×	90 0.4×	582 2.6×	80	2.7k
Michael J. Campa United States	20	827 0.7×	595 1.0×	153 0.5×	181 0.8×	233 1.0×	56	1.8k
Takaki Hiwasa Japan	25	1.3k 1.0×	474 0.8×	386 1.1×	221 0.9×	67 0.3×	132	2.1k
Michele Signore Italy	30	1.4k 1.2×	799 1.3×	737 2.2×	108 0.5×	43 0.2×	60	2.4k
Alessandra Tessitore Italy	28	1.2k 1.0×	424 0.7×	521 1.5×	77 0.3×	85 0.4×	80	2.6k
Jan Bouchal Czechia	27	1.5k 1.2×	939 1.6×	613 1.8×	96 0.4×	55 0.2×	86	2.6k
Stefania Tommasi Italy	28	1.5k 1.2×	828 1.4×	846 2.5×	84 0.4×	88 0.4×	139	2.7k

Countries citing papers authored by Jianghong Deng

Since Specialization

Citations

This map shows the geographic impact of Jianghong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianghong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianghong Deng more than expected).

Fields of papers citing papers by Jianghong Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianghong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianghong Deng. The network helps show where Jianghong Deng may publish in the future.

Co-authorship network of co-authors of Jianghong Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Jianghong Deng. A scholar is included among the top collaborators of Jianghong Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianghong Deng. Jianghong Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Xinwei, Jianghong Deng, Junmei Zhang, et al.. (2025). Long-term prognosis of 47 pediatric patients with Blau syndrome in China. PubMed. 25(1). 374–374.

Zhao, Xiaozhen, Jianghong Deng, Chao Li, et al.. (2024). Evaluating treatment practices and challenges in systemic Juvenile Idiopathic Arthritis: a comprehensive survey analysis. Clinical Rheumatology. 43(11). 3469–3475.

Li, Shipeng, Xia Wang, Xiaozhen Zhao, et al.. (2024). Long noncoding nuclear enriched abundant transcript 1_2 is a promising biomarker for childhood‐onset systemic lupus erythematosus. Pediatric Investigation. 8(2). 101–107. 1 indexed citations

Zhao, Xiaozhen, Junmei Zhang, Caifeng Li, et al.. (2024). Mitochondrial mechanisms in Treg cell regulation: Implications for immunotherapy and disease treatment. Mitochondrion. 80. 101975–101975. 8 indexed citations

Li, Shipeng, et al.. (2023). Age-related differences in clinical and laboratory characteristics of childhood-onset systemic lupus erythematosus: Pre-puberal-onset SLE is prone to delayed diagnosis. Lupus. 32(14). 1675–1680. 4 indexed citations

Deng, Jianghong, et al.. (2023). Lipid profiles in patients with juvenile idiopathic arthritis: a systematic literature review and meta-analysis. Lipids in Health and Disease. 22(1). 136–136. 3 indexed citations

Zhang, Junmei, Li Sun, Xin‐Wei Shi, et al.. (2023). Janus kinase inhibitor, tofacitinib, in refractory juvenile dermatomyositis: a retrospective multi-central study in China. Arthritis Research & Therapy. 25(1). 204–204. 8 indexed citations

Zhao, Xiaozhen, Junmei Zhang, Caifeng Li, et al.. (2022). Early onset is an indication of the severity of DADA2 disease. Lara D. Veeken. 62(2). 969–976. 1 indexed citations

Deng, Jianghong, et al.. (2022). Research progress in drug therapy of juvenile idiopathic arthritis. World Journal of Pediatrics. 18(6). 383–397. 2 indexed citations

10.

Zhang, Junmei, et al.. (2019). Analyses of gene mutation, clinical phenotype, treatment and follow up of 10 cases with chronic infantile neurologic, cutaneous, articular syndrome. 23(8). 536–539. 1 indexed citations

11.

Li, Caifeng, et al.. (2017). Gene mutations and clinical phenotypes in 15 Chinese children with cryopyrin-associated periodic syndrome (CAPS). Science China Life Sciences. 60(12). 1436–1444. 14 indexed citations

12.

Zhang, Ying, Yanzhi Yang, Fadila Guessous, et al.. (2013). Hepatocyte Growth Factor Sensitizes Brain Tumors to c-MET Kinase Inhibition. Clinical Cancer Research. 19(6). 1433–1444. 29 indexed citations

13.

Chiechi, Antonella, Chiara Novello, Giovanna Magagnoli, et al.. (2013). Elevated TNFR1 and Serotonin in Bone Metastasis Are Correlated with Poor Survival following Bone Metastasis Diagnosis for Both Carcinoma and Sarcoma Primary Tumors. Clinical Cancer Research. 19(9). 2473–2485. 28 indexed citations

14.

Wulfkuhle, Julia, Daniela Berg, Claudia Wolff, et al.. (2012). Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping. Clinical Cancer Research. 18(23). 6426–6435. 85 indexed citations

15.

Einspahr, Janine G., Valerie Calvert, David S. Alberts, et al.. (2012). Functional Protein Pathway Activation Mapping of the Progression of Normal Skin to Squamous Cell Carcinoma. Cancer Prevention Research. 5(3). 403–413. 71 indexed citations

16.

Mammano, Enzo, Mariaelena Pierobon, Jianghong Deng, et al.. (2012). Multiplexed Protein Signal Pathway Mapping Identifies Patients With Rectal Cancer That Responds to Neoadjuvant Treatment. Clinical Colorectal Cancer. 11(4). 268–274. 5 indexed citations

17.

Silvestri, Alessandra, Valerie Calvert, Claudio Belluco, et al.. (2012). Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations. Clinical & Experimental Metastasis. 30(3). 309–316. 12 indexed citations

18.

Zupa, Angela, Giuseppina Improta, Alessandra Silvestri, et al.. (2012). A Pilot Characterization of Human Lung NSCLC by Protein Pathway Activation Mapping. Journal of Thoracic Oncology. 7(12). 1755–1766. 22 indexed citations

19.

Grubb, Robert L., Jianghong Deng, Peter A. Pinto, et al.. (2009). Pathway Biomarker Profiling of Localized and Metastatic Human Prostate Cancer Reveal Metastatic and Prognostic Signatures. Journal of Proteome Research. 8(6). 3044–3054. 42 indexed citations

20.

Zhou, Jiangbing, Julia Wulfkuhle, Hao Zhang, et al.. (2007). Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proceedings of the National Academy of Sciences. 104(41). 16158–16163. 539 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact